Camber Capital Takes Big Position in Med-Tech Company Biolase

Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ:BIOL). In a filing with the Securities and Exchange Commission, Stephen Dubois’ fund disclosed ownership of slightly below 2.7 million shares, which have a value of $5.4 million. The new position represents around 7.3% of Biolase.

Disclosure: none